Identifying and Managing NASH in High-Risk Populations

Slides outlining why it’s crucial to look for fatty liver disease and NASH, how to identify it, and what you can do about it in your practice.
Manal F. Abdelmalek, MD, MPH
Saleh A. Alqahtani, MBChB
Zobair Younossi Headshot
Zobair M. Younossi, MD, MPH, FACP, FACG, AGAF, FAASLD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.17 MB
Released: February 5, 2019


Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Tina B. Stacy, PharmD, BCOP, CHCP
(404) 425-4474

In partnership with
Health Trucking Association of America (HTAA) Logo
Fatty Liver Foundation Logo
Supported by an educational grant from
Gilead Sciences, Inc.

Related Content

EASL 2019 downloadable slideset: Phase II efficacy and safety results of emricasan, an oral caspase inhibitor, in NASH cirrhosis and severe portal HTN as reported by Clinical Care Options (CCO)

Released: April 17, 2019

Planned Month 18 interim analysis of phase III REGENERATE study of obeticholic acid vs placebo for NASH from EASL 2019, reported by CCO

Released: April 16, 2019

Kenneth Cusi, MD, FACP, FACE, explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.

Kenneth Cusi, MD, FACP, FACE Released: March 29, 2019

Stephen A. Harrison, MD, COL (Ret.), FAASLD, explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.

Stephen A. Harrison, MD, COL (Ret.), FAASLD Released: March 29, 2019

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?